Hans Kreipe

1.6k total citations
67 papers, 1.0k citations indexed

About

Hans Kreipe is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans Kreipe has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans Kreipe's work include Acute Myeloid Leukemia Research (9 papers), Breast Cancer Treatment Studies (8 papers) and Cancer Genomics and Diagnostics (6 papers). Hans Kreipe is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Breast Cancer Treatment Studies (8 papers) and Cancer Genomics and Diagnostics (6 papers). Hans Kreipe collaborates with scholars based in Germany, United States and Switzerland. Hans Kreipe's co-authors include Ulrich Lehmann, Florian Länger, H. J. Radzun, M R Parwaresch, Carmen Hernández, H J Heidebrecht, M. L. Hansmann, Hans Wacker, C Kuhn and Danny Jonigk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Hans Kreipe

66 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Kreipe Germany 16 330 323 246 177 166 67 1.0k
Shrihari S. Kadkol United States 21 376 1.1× 602 1.9× 189 0.8× 158 0.9× 128 0.8× 41 1.2k
Fionnuala O’Connell Ireland 14 406 1.2× 468 1.4× 253 1.0× 255 1.4× 202 1.2× 22 1.2k
Naoko Okayama Japan 20 403 1.2× 643 2.0× 288 1.2× 148 0.8× 135 0.8× 70 1.3k
Gigliola Reato Italy 18 542 1.6× 484 1.5× 262 1.1× 175 1.0× 298 1.8× 36 1.4k
Jean‐Philippe Rougier France 10 453 1.4× 525 1.6× 380 1.5× 145 0.8× 75 0.5× 13 1.3k
Roberta Fasani Italy 18 326 1.0× 577 1.8× 206 0.8× 220 1.2× 207 1.2× 53 1.4k
Jeffrey C. Hanson United States 21 254 0.8× 590 1.8× 246 1.0× 210 1.2× 140 0.8× 39 1.2k
Muh‐Hwa Yang Taiwan 16 456 1.4× 465 1.4× 245 1.0× 161 0.9× 69 0.4× 56 1.3k
Lionel D’Hondt Belgium 19 309 0.9× 363 1.1× 177 0.7× 340 1.9× 68 0.4× 65 1.1k
Julia Calzada‐Wack Germany 22 233 0.7× 665 2.1× 138 0.6× 177 1.0× 172 1.0× 40 1.2k

Countries citing papers authored by Hans Kreipe

Since Specialization
Citations

This map shows the geographic impact of Hans Kreipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Kreipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Kreipe more than expected).

Fields of papers citing papers by Hans Kreipe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Kreipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Kreipe. The network helps show where Hans Kreipe may publish in the future.

Co-authorship network of co-authors of Hans Kreipe

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Kreipe. A scholar is included among the top collaborators of Hans Kreipe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Kreipe. Hans Kreipe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartels, Stephan, Elisa Schipper, Razif Gabdoulline, et al.. (2025). Cell‐free DNA for detection and monitoring of extramedullary AML relapse. HemaSphere. 9(3). e70097–e70097. 2 indexed citations
2.
Jóźwiak, Katarzyna, Mieke Raap, Stephan Bartels, et al.. (2025). Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial. Laboratory Investigation. 105(6). 104125–104125. 2 indexed citations
3.
Kreipe, Hans & Brigitte Schlegelberger. (2024). Cytogenetics and genomics in CML and other myeloproliferative neoplasms. Best Practice & Research Clinical Haematology. 37(2). 101552–101552. 2 indexed citations
4.
Kolberg-Liedtke, Cornelia, Oleg Gluz, Friedrich Feuerhake, et al.. (2020). Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)—a translational analysis of the prospective WSG PlanB trial. Breast Cancer Research. 22(1). 47–47. 19 indexed citations
5.
Bartels, Stephan, et al.. (2017). Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice. Journal of Molecular Diagnostics. 19(5). 722–732. 37 indexed citations
7.
Kreipe, Hans, et al.. (2014). Proliferationsbestimmung beim Mammakarzinom durch den immunhistochemischen Nachweis von Ki-67. Der Pathologe. 35(1). 54–60. 6 indexed citations
8.
Christgen, Matthias, Matthias Ballmaier, Ulrich Lehmann, & Hans Kreipe. (2012). Detection of Putative Cancer Stem Cells of the Side Population Phenotype in Human Tumor Cell Cultures. Methods in molecular biology. 878. 201–215. 15 indexed citations
9.
Ripperger, Tim, Carmela Beger, Nils Rahner, et al.. (2009). Constitutional mismatch repair deficiency and childhood leukemia/lymphoma - report on a novel biallelic MSH6 mutation. Haematologica. 95(5). 841–844. 38 indexed citations
10.
Ströbel, Philipp, Mirella Marino, Martin Feuchtenberger, et al.. (2005). Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development. The Journal of Pathology. 207(1). 72–82. 39 indexed citations
11.
Traub, Frank, Henning Feist, Hans Kreipe, & Andreas Pich. (2005). SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas. Pathology - Research and Practice. 201(12). 763–770. 20 indexed citations
12.
Bock, Oliver, Torsten Kirsch, H. Haller, et al.. (2005). Compartment-specific quantitative gene expression analysis after laser microdissection from archival renal allograft biopsies. Clinical Nephrology. 63(3). 193–201. 6 indexed citations
14.
Flemming, Peer, Thomas Becker, J. Klempnauer, et al.. (2002). Benign Cystic Mesothelioma of the Liver. The American Journal of Surgical Pathology. 26(11). 1523–1527. 15 indexed citations
15.
Lehmann, Ulrich, et al.. (2000). Quantitative Molecular Analysis of Laser-Microdissected Paraffin- Embedded Human Tissues. Pathobiology. 68(4-5). 202–208. 32 indexed citations
16.
Feist, H., et al.. (1998). Induction of telomerase activity in stimulated human lymphocytes precedes expression of topoisomerase II α. Annals of Hematology. 76(3-4). 111–115. 5 indexed citations
17.
Bastian, Boris C., Hans Kreipe, & E.‐B. Bröcker. (1996). Primary Neuroendocrine Carcinoma of the Skin with an Unusual Follicular Lymphocytic Infiltrate of the Dermis. American Journal of Dermatopathology. 18(6). 625–628. 10 indexed citations
18.
Kreipe, Hans, et al.. (1991). Increased Methylation of the <i>c-fms</i>Protooncogene in Acute Myelomonocytic Leukemias. Pathobiology. 59(4). 293–298. 13 indexed citations
19.
Barth, Jürgen, et al.. (1989). [Spontaneous interleukin 1 secretion by alveolar macrophages from the bronchoalveolar lavage of patients with active sarcoidosis].. PubMed. 17(4). 141–4. 1 indexed citations
20.
Radzun, H. J., Hans Kreipe, Hans Wacker, & M R Parwaresch. (1985). Monocyte macrophage heterogeneity as shown by monoclonal antibodies and monocyte macrophage hybrids. Annals of Hematology. 51(3). 201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026